11 Results for "

recombinant human DPP4

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "recombinant human DPP4" in MCE Product Catalog:

Cat. No.: HY-14892A
CAS No.: 1374639-74-3
Purity:  98.17%
Synonyms: LC15-0444 tartrate
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

Gemigliptin tartrate (LC15-0444 tartrate) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibits potent anti-glycation properties. Gemigliptin tartrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications .
loading...
    loading...
Cat. No.: HY-14892
CAS No.: 911637-19-9
Synonyms: LC15-0444
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease Cancer

Gemigliptin (LC15-0444 ) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin exhibits potent anti-glycation properties. Gemigliptin can be used for the research of advanced glycation end products (AGE)-related diabetic complications .
loading...
    loading...
Cat. No.: HY-P4344
CAS No.: 1926163-52-1
Met-Gly-Pro-AMC is a fluorescent peptide substrate active against *Caenorhabditis elegans* DPF-3, hDPP4, and methionyl aminopeptidase 2 (MetAP2). Met-Gly-Pro-AMC undergoes cleavage via tripeptidyl peptidase activity to release a fluorescent product. Met-Gly-Pro-AMC is used to detect the activities of tripeptidyl peptidases and MetAP2 peptidases in in vitro enzyme activity assays .
loading...
    loading...
Cat. No.: HY-P1348
CAS No.: 1197810-60-8
Synonyms: [Gly8,36,Glu22]-GLP-1 (7-37)
Research Areas:  

Metabolic Disease

GLP-1 moiety from Dulaglutide ([Gly8,36,Glu22]-GLP-1 (7-37)) is a 31-amino acid fragment derived from Dulaglutide (HY-P0120). GLP-1 moiety from Dulaglutide is a DPP-4-modified GLP-1 analog carrying the [Gly8,36,Glu22] sequence mutation, which acts as a GLP-1 receptor agonist. GLP-1 moiety from Dulaglutide covalently links to the human IgG4 Fc fragment and constitutes a part of the dulaglutide recombinant fusion protein. GLP-1 moiety from Dulaglutide exhibits glucose-dependent insulinotropic activity. GLP-1 moiety from Dulaglutide can be used in research related to type 2 diabetes .
loading...
    loading...
Cat. No.: HY-14892C
CAS No.: 1523530-62-2
Synonyms: LC15-0444 hydrochloride
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease Cancer

Gemigliptin hydrochloride is the hydrochloride salt of Gemigliptin (HY-14892). Gemigliptin hydrochloride is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin hydrochloride exhibits potent anti-glycation properties. Gemigliptin hydrochloride can be used for the research of advanced glycation end products (AGE)-related diabetic complications .
loading...
    loading...
Cat. No.: HY-14806R
CAS No.: 760937-92-6
Synonyms: MP-513 (Standard)
Teneligliptin (Standard) is the analytical standard of Teneligliptin. This product is intended for research and analytical applications. Teneligliptin (MP-513) is a potent, orally available, competitive, and long-lasting DPP-4 inhibitor. Teneligliptin competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM .
loading...
    loading...
Cat. No.: HY-14892B
CAS No.: 1375415-82-9
Synonyms: LC15-0444 tartrate hydrate
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

Gemigliptin (LC15-0444 ) tartrate hydrate is a selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate hydrate exhibits potent anti-glycation properties. Gemigliptin tartrate hydrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications .
loading...
    loading...
Cat. No.: HY-14806S1
Synonyms: MP-513-d4
Teneligliptin-d4 is deuterium labeled Teneligliptin. Teneligliptin (MP-513) is a potent, orally available, competitive, and long-lasting DPP-4 inhibitor. Teneligliptin competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM .
loading...
    loading...
Cat. No.: HY-111294
CAS No.: 851389-35-0
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

ASP4000 hydrochloride is a potent, competitive, selective, orally active DPP4 inhibitor with an IC50 value of 2.25 nM against human recombinant DPP4. ASP4000 hydrochloride shows antihyperglycemic activity. ASP4000 hydrochloride can be used in the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-109060
CAS No.: 1601479-87-1
Synonyms: ZYDPLA1
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

Garvagliptin (ZYDPLA1) is an orally active, competitive and long acting DPP4 Inhibitor, with an IC50 of 2.99 nM against human recombinant DPP IV. Garvagliptin (ZYDPLA1) exhibits antihyperglycemic effect .
loading...
    loading...
Cat. No.: HY-P5311
CAS No.: 782500-75-8
Synonyms: GSK-716155

Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

Albiglutide is a long acting GLP-1 receptor agonist. Albiglutide is a recombinant fusion protein consisting of two copies of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36), modified with a glycine substituted for the naturally occurring alanine at position 8 in order to augment resistance to DPP-4. Albiglutide can be used for research of Type 2 diabetes .
loading...
    loading...
  • 1